Renal damage during treatment with antirheumatic drugs.
作者信息
Dieppe P A, Doyle D V, Burry H C
出版信息
Br Med J. 1978 Sep 2;2(6138):664. doi: 10.1136/bmj.2.6138.664.
Abstract
摘要
相似文献
1
Renal damage during treatment with antirheumatic drugs.抗风湿药物治疗期间的肾损伤。
Br Med J. 1978 Sep 2;2(6138):664. doi: 10.1136/bmj.2.6138.664.
2
N-acetyl-beta-D-glucosaminidase enzymuria as an indicator in monitoring the therapy of some rheumatic diseases with potentially nephrotoxic drugs.
Arch Immunol Ther Exp (Warsz). 1994;42(4):331-6.
3
[Rheumatic collagen diseases and drug-induced kidney disorders].[风湿性胶原疾病与药物性肾脏疾病]
Nihon Rinsho Meneki Gakkai Kaishi. 2002 Jun;25(3):255-62.
4
[Not Available].[无可用内容]
Dtsch Med Wochenschr. 2017 Nov;142(23):1775-1777. doi: 10.1055/s-0043-112254. Epub 2017 Nov 16.
5
Non steroidal anti-inflammatory drugs.非甾体抗炎药
Aust Fam Physician. 1987 Jun;16(6):799, 803, 805 passim.
6
[Early diagnosis of kidney disorders induced by nephrotoxic substances].
Nihon Naika Gakkai Zasshi. 1994 Oct 10;83(10):1720-3.
7
[Drug-induced kidney diseases. I. Analgesics and non-steroidal antirheumatic drugs].[药物性肾病。I. 镇痛药和非甾体类抗风湿药]
Med Monatsschr Pharm. 1986 Nov;9(11):331-7.
8
9
DNA single strand-breaks in human lymphocytes after therapy with antirheumatic drugs.抗风湿药物治疗后人类淋巴细胞中的DNA单链断裂
Arzneimittelforschung. 1991 Nov;41(11):1141-4.
10
[Renal function tests in patients with rheumatoid arthritis].[类风湿关节炎患者的肾功能测试]
Nihon Rinsho. 2005 Jan;63 Suppl 1:375-8.
引用本文的文献
1
Urinary N-acetyl-beta-D glucosaminidase (NAG) level in idiopathic nephrotic syndrome.特发性肾病综合征患者尿液 N-乙酰-β-D-氨基葡萄糖苷酶（NAG）水平。
Pediatr Nephrol. 2012 Apr;27(4):589-96. doi: 10.1007/s00467-011-2041-4. Epub 2011 Nov 5.
2
Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats.对导致雄性大鼠肾脏中α2u-球蛋白蓄积、透明滴状肾病和肾小管肿瘤形成的化学物质的危害评估。
Environ Health Perspect. 1993 Mar;99:313-49. doi: 10.1289/ehp.9399313.
3
Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment.α2u-球蛋白肾病：参与的细胞和分子机制及其对人类风险评估的影响综述
Environ Health Perspect. 1993 Dec;101 Suppl 6(Suppl 6):39-44. doi: 10.1289/ehp.93101s639.
4
Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.用双去氧卡那霉素或庆大霉素治疗的健康志愿者尿中N-乙酰-β-葡萄糖苷酶排泄情况的评估。
Antimicrob Agents Chemother. 1982 Jun;21(6):1013-5. doi: 10.1128/AAC.21.6.1013.
5
Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.镇痛剂肾病：对非那西丁及其他镇痛剂作用的重新评估
Drugs. 1982 Jan-Feb;23(1-2):75-149. doi: 10.2165/00003495-198223010-00004.
6
The effects of levamisole on urinary enzyme measurements and proximal tubule cell inclusions in male rats.左旋咪唑对雄性大鼠尿酶测定及近端肾小管细胞内含物的影响。
Br J Exp Pathol. 1988 Apr;69(2):301-8.
7
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.肾衰竭、类风湿关节炎及老年对二氟尼柳药代动力学的影响。
Eur J Clin Pharmacol. 1989;36(2):165-74. doi: 10.1007/BF00609190.
8
The kidney in rheumatic diseases.风湿性疾病中的肾脏
Ann Rheum Dis. 1989 Dec;48(12):1029-30. doi: 10.1136/ard.48.12.1029.
9
An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritis.对半衰期较长的非甾体抗炎药替诺昔康在患有骨关节炎或类风湿性关节炎的肾功能受损患者中的评估。
Clin Rheumatol. 1989 Dec;8(4):453-60. doi: 10.1007/BF02032096.
10
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.萘普生最新进展：对其药理特性、治疗效果以及在风湿性疾病和疼痛状态中的应用的综述。
Drugs. 1979 Oct;18(4):241-77. doi: 10.2165/00003495-197918040-00001.
本文引用的文献
1
Evidence of gentamicin nephrotoxicity in patients with renal allografts.肾移植患者中庆大霉素肾毒性的证据。
Br Med J. 1975 Aug 2;3(5978):278-81. doi: 10.1136/bmj.3.5978.278.
Zotero 插件